NO884434D0 - Aminosyrederivater. - Google Patents

Aminosyrederivater.

Info

Publication number
NO884434D0
NO884434D0 NO884434A NO884434A NO884434D0 NO 884434 D0 NO884434 D0 NO 884434D0 NO 884434 A NO884434 A NO 884434A NO 884434 A NO884434 A NO 884434A NO 884434 D0 NO884434 D0 NO 884434D0
Authority
NO
Norway
Prior art keywords
amino acid
acid derivative
derivative
amino
acid
Prior art date
Application number
NO884434A
Other languages
English (en)
Other versions
NO884434L (no
Inventor
Quirico Branca
Albrecht Edenhofer
Eva-Maria Gutknecht
Werner Neidhart
Henri Ramuz
Wolfgang Wostl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO884434D0 publication Critical patent/NO884434D0/no
Publication of NO884434L publication Critical patent/NO884434L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/08Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1024Tetrapeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO88884434A 1987-10-06 1988-10-05 Aminosyrederivater. NO884434L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH390387 1987-10-06

Publications (2)

Publication Number Publication Date
NO884434D0 true NO884434D0 (no) 1988-10-05
NO884434L NO884434L (no) 1989-04-07

Family

ID=4265984

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88884434A NO884434L (no) 1987-10-06 1988-10-05 Aminosyrederivater.

Country Status (14)

Country Link
EP (1) EP0310918A3 (no)
JP (1) JPH02256658A (no)
KR (1) KR890006572A (no)
AU (1) AU627156B2 (no)
DK (1) DK523288A (no)
FI (1) FI884598A (no)
HU (1) HUT49322A (no)
IL (1) IL87871A0 (no)
MC (1) MC1985A1 (no)
NO (1) NO884434L (no)
NZ (1) NZ226395A (no)
PT (1) PT88679A (no)
YU (1) YU185188A (no)
ZA (1) ZA887322B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU595309B2 (en) * 1986-05-09 1990-03-29 Dainippon Pharmaceutical Co. Ltd. Tripeptide derivatives
US4895834A (en) * 1986-12-15 1990-01-23 Warner-Lambert Company Renin inhibitors III
US5023236A (en) * 1988-04-07 1991-06-11 Corvas, Inc. Factor VII/VIIA active site inhibitors
EP0391180A3 (de) * 1989-04-04 1991-04-03 F. Hoffmann-La Roche Ag Peptidartige Aminosäurederivate mit reninhemmender Wirkung
CA2012901A1 (en) * 1989-04-05 1990-10-05 Quirico Branca Amino acid derivatives
FI904441A0 (fi) * 1989-09-12 1990-09-10 Hoechst Ag Aminosyraderivat med reninhaemmande egenskaper, foerfaranden foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning.
DE4008403A1 (de) * 1990-03-16 1991-09-19 Merck Patent Gmbh Glykolsaeurederivate
US5516784A (en) * 1991-08-13 1996-05-14 Schering Corporation Anti-HIV (AIDS) agents
US5422349A (en) * 1992-08-14 1995-06-06 G. D. Seale & Co. Morpholino-oxazinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
AU6161794A (en) * 1993-01-17 1994-08-15 Schering Corporation Peptides having anti-hiv activity
US5563127A (en) * 1993-03-24 1996-10-08 The Dupont Merck Pharmaceutical Company Boronic acid and ester inhibitors of thrombin
FR2741066B1 (fr) * 1995-11-14 1997-12-12 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
FR2752422B1 (fr) * 1996-08-16 1998-11-06 Lipha Composition pharmaceutique contenant des acides 4-oxo-butanoiques
BR9911785A (pt) * 1998-05-12 2001-04-03 Warner Lambert Co Combinações de farnesil transferase de proteìna e inibidores de redutase de hmg coa e seu uso para tratar câncer
HUE040417T2 (hu) * 2007-05-04 2019-03-28 Marina Biotech Inc Aminosavlipidek és alkalmazásuk
GB0919194D0 (en) 2009-11-02 2009-12-16 Lytix Biopharma As Compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652551A (en) * 1984-06-22 1987-03-24 Abbott Laboratories Renin inhibiting compounds
DK34086A (da) * 1985-01-23 1986-07-24 Abbott Lab Peptidylaminodioler
IL81234A (en) * 1986-01-16 1992-09-06 Abbott Lab Peptidylaminodiols,process for their preparation and pharmaceutical compositions comprising them
US4792555A (en) * 1987-03-20 1988-12-20 American Home Products Corporation Phospholipase A2 inhibitors

Also Published As

Publication number Publication date
YU185188A (en) 1990-12-31
NZ226395A (en) 1991-12-23
IL87871A0 (en) 1989-03-31
AU2330788A (en) 1989-06-08
NO884434L (no) 1989-04-07
DK523288A (da) 1989-04-07
FI884598A0 (fi) 1988-10-06
AU627156B2 (en) 1992-08-20
ZA887322B (en) 1989-06-28
DK523288D0 (da) 1988-09-20
FI884598A (fi) 1989-04-07
MC1985A1 (fr) 1989-11-23
JPH02256658A (ja) 1990-10-17
EP0310918A3 (de) 1990-12-12
KR890006572A (ko) 1989-06-14
PT88679A (pt) 1989-07-31
HUT49322A (en) 1989-09-28
EP0310918A2 (de) 1989-04-12

Similar Documents

Publication Publication Date Title
NO892407D0 (no) Aminosyrederivater.
NO901399D0 (no) Aminosyrederivater.
DK340088D0 (da) Aminosyrederivater
NO903832L (no) Aminosyrederivater.
NO901033L (no) Aminosyrederivater.
DE3854495D1 (de) Tetrapyrrolaminocarbonsäuren.
DE3872937D1 (de) Benzoylaminophenoxybuttersaeure-derivate.
NO884434L (no) Aminosyrederivater.
DE3787657D1 (de) Aminosäure-Derivate.
ATE90079T1 (de) Substituierte 2-phenyl-4-chinolincarbonsaeuren.
NO901533L (no) Aminosyrederivater.
NO890635L (no) Reninhemmende aminosyrederivater.
NO912537L (no) Aminosyrederivater.
NO884361L (no) Katechol-karboksylsyrederivater.
NO892728D0 (no) Aminoalkyl-aminokarbonyl-aminodiolaminosyre derivater somanti-hypertensive midler.
NO885005D0 (no) Vannavstende belegg.
DE3851615D1 (de) Hydroxamsäure-Derivate.
DE69018816D1 (de) Aminosäurederivate.
NO901519D0 (no) Aminosyrederivater.
DE3864841D1 (de) Carbonsaeure-derivate.
DK9588A (da) 2,1-benzothiazepin-2,2-dioxid-5-carboxylsyrederivater
DE3854064D1 (de) Hydrochinonylphenyl-Buttersäureamid-Derivate.
DE3854436D1 (de) Alkoxymethylbenzoesäure.
NO870781L (no) Aminosyrederivater.
ATE95518T1 (de) Aminosaeure-derivate.